The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISLB 2022 | Current challenges for lung cancer patients due to COVID-19
Amy Moore, PhD, Lungevity Foundation, USA, discusses the challenges that patients with lung cancer are facing, nearly three years since the start of the pandemic. Dr Moore talks on research into the immune response to the COVID-19 vaccine in patients with lung cancer, which reported that these patients can still experience severe breakthrough infections. Therefore, people with lung cancer still need to take precautions, such as taking any vaccine boosters on offer and wearing masks in crowded spaces, which can also protect against other respiratory viruses such as the flu. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Advisory Board: Bayer, Pfizer, Novartis, Exact Sciences, Jazz Pharmaceuticals, Debiopharm
